{"transactions":[{"id":1878192,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T16:47:59.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023."}],"balance_after":50000,"derivative":{"exercise_price":0.3025,"exercise_date":"2023-05-23","expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-23-043129","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390023043129/ownership.xml","form_type":"4"}},{"id":1878191,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T16:47:59.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":240800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1261779,"source":{"system":"sec-edgar","filing":"0001213900-23-043129","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390023043129/ownership.xml","form_type":"4"}},{"id":1963369,"issuer":{"id":8466,"kind":"organization","name":"Change Agents Corporation."},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T16:45:24.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest over one year in equal quarterly installments."}],"balance_after":8000,"derivative":{"exercise_price":11.2,"expiration_date":"2025-12-31","underlying":"Common Stock, $.0001 par value","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001213900-23-018585","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390023018585/ownership.xml","form_type":"4"}},{"id":1963368,"issuer":{"id":8466,"kind":"organization","name":"Change Agents Corporation."},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T16:45:24.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest over one year in equal quarterly installments."}],"balance_after":8000,"derivative":{"exercise_price":8.2,"expiration_date":"2026-12-31","underlying":"Common Stock, $.0001 par value","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001213900-23-018585","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390023018585/ownership.xml","form_type":"4"}},{"id":1963367,"issuer":{"id":8466,"kind":"organization","name":"Change Agents Corporation."},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T16:45:24.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest over one year in equal quarterly installments."}],"balance_after":8000,"derivative":{"exercise_price":5.2,"expiration_date":"2027-12-31","underlying":"Common Stock, $.0001 par value","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001213900-23-018585","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390023018585/ownership.xml","form_type":"4"}},{"id":2072707,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-03T06:02:37.000Z","date":"2022-12-30","kind":"disposition_to_issuer","acquired":false,"shares":166667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the cancellation of 166,667 previously outstanding shares of restricted common stock of Adial Pharmaceuticals, Inc. originally issued on February 23, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents the cancellation of 166,667 previously outstanding shares of restricted common stock of Adial Pharmaceuticals, Inc. originally issued on February 23, 2022."}],"balance_after":1020979,"source":{"system":"sec-edgar","filing":"0001213900-23-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390023000003/ownership.xml","form_type":"4"}},{"id":2176143,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-08-23T19:14:33.000Z","date":"2022-08-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options to purchase 100,000 shares of the Company's common stock, vesting 50% after Purnovate, Inc. has held a pre-IND meeting with the FDA and the balance when the IND is granted."}],"balance_after":100000,"derivative":{"exercise_price":0.555,"exercise_date":"2022-09-01","expiration_date":"2032-08-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-22-050596","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390022050596/ownership.xml","form_type":"4"}},{"id":2372189,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-25T15:00:40.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted shares of Adial Pharmaceuticals, Inc. (the \"Company\") common stock, par value $0.001 per share (the \"Common Stock\"), vest as to 166,667 shares monthly on a pro rata basis over 24 months commencing March 23, 2022 and vest as to 83,333 shares on the three year anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The restricted shares of Adial Pharmaceuticals, Inc. (the \"Company\") common stock, par value $0.001 per share (the \"Common Stock\"), vest as to 166,667 shares monthly on a pro rata basis over 24 months commencing March 23, 2022 and vest as to 83,333 shares on the three year anniversary of the grant date."}],"balance_after":1187646,"source":{"system":"sec-edgar","filing":"0001213900-22-009432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390022009432/ownership.xml","form_type":"4"}},{"id":2490661,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-01T09:25:37.000Z","date":"2021-11-30","kind":"purchase","acquired":true,"shares":10600,"price":2.7527,"value":29178.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted average price. These 10,600 shares of common stock were purchased in multiple transactions at prices ranging from $2.5999 to $2.83, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These 10,600 shares of common stock were purchased in multiple transactions at prices ranging from $2.5999 to $2.83, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4"}],"balance_after":937646,"source":{"system":"sec-edgar","filing":"0001213900-21-062729","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390021062729/ownership.xml","form_type":"4"}},{"id":2490660,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-01T09:25:37.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":10000,"price":2.5892,"value":25892.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted average price. These 10,000 shares of common stock were purchased in multiple transactions at prices ranging from $2.54 to $2.60, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These 10,000 shares of common stock were purchased in multiple transactions at prices ranging from $2.54 to $2.60, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4"}],"balance_after":927046,"source":{"system":"sec-edgar","filing":"0001213900-21-062729","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390021062729/ownership.xml","form_type":"4"}},{"id":2573299,"issuer":{"id":130977,"kind":"organization","name":"Sysorex, Inc.","symbol":"SYSX"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-10T20:45:45.000Z","date":"2021-09-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Common Stock were granted in connection with the Reporting Person's services as director."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001213900-21-047517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390021047517/ownership.xml","form_type":"4"}},{"id":2869304,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2021-02-10T18:10:24.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":250000,"derivative":{"exercise_price":3.11,"exercise_date":"2021-03-08","expiration_date":"2031-02-07","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001213900-21-008172","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390021008172/ownership.xml","form_type":"4"}},{"id":2892192,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-28T19:45:34.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":201109,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired 201,109 shares of issuer common stock in exchange for an 28.7% interest in Purnovate, LLC (\"Purnovate\") pursuant to Purnovate's merger into a wholly owned subsidiary of the issuer, as contemplated by that certain Equity Purchase Agreement, dated December 7, 2020, as amended. The shares issued to the reporting person in the merger are currently being held in escrow and are subject to forfeiture during the two-year period following the merger to satisfy claims arising as a result of Purnovate's breach of any of its representations and warranties or covenants in the purchase agreement."}],"balance_after":917046,"source":{"system":"sec-edgar","filing":"0001213900-21-005043","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390021005043/ownership.xml","form_type":"4"}},{"id":3193294,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-27T06:03:33.000Z","date":"2020-03-26","kind":"purchase","acquired":true,"shares":12652,"price":1.47,"value":18598.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted average price. These 12,652 shares of common stock were purchased in multiple transactions at prices ranging from $1.4350 to $1.50, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These 12,652 shares of common stock were purchased in multiple transactions at prices ranging from $1.4350 to $1.50, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":715937,"source":{"system":"sec-edgar","filing":"0001213900-20-007568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390020007568/ownership.xml","form_type":"4"}},{"id":3193293,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-27T06:03:33.000Z","date":"2020-03-25","kind":"purchase","acquired":true,"shares":12348,"price":1.13,"value":13953.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted average price. These 12,348 shares of common stock were purchased in multiple transactions at prices ranging from $1.08 to $1.2708, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These 12,348 shares of common stock were purchased in multiple transactions at prices ranging from $1.08 to $1.2708, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4"}],"balance_after":703285,"source":{"system":"sec-edgar","filing":"0001213900-20-007568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390020007568/ownership.xml","form_type":"4"}},{"id":3224696,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2020-03-05T19:20:46.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":460000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":460000,"derivative":{"exercise_price":1.44,"exercise_date":"2020-04-03","expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":460000},"source":{"system":"sec-edgar","filing":"0001213900-20-005545","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390020005545/ownership.xml","form_type":"4"}},{"id":3224695,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2020-03-05T19:20:46.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":54167,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":690937,"source":{"system":"sec-edgar","filing":"0001213900-20-005545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390020005545/ownership.xml","form_type":"4"}},{"id":3249588,"issuer":{"id":8466,"kind":"organization","name":"Change Agents Corporation."},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-02-25T16:11:03.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":80000,"price":1.52,"value":121600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options vest over one year in equal quarterly installments."}],"balance_after":80000,"derivative":{"exercise_price":1.52,"exercise_date":"2020-02-25","expiration_date":"2020-02-25","underlying":"Common Stock, $.0001 par value","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001213900-20-004742","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390020004742/ownership.xml","form_type":"4"}},{"id":3599503,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2019-03-12T18:45:21.000Z","date":"2019-03-10","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over 36 months."}],"balance_after":500000,"derivative":{"exercise_price":3.39,"exercise_date":"2019-04-10","expiration_date":"2029-03-09","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-19-004001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390019004001/ownership.xml","form_type":"4"}},{"id":3767502,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to purchase common stock","published_at":"2018-11-13T18:05:35.000Z","date":"2018-11-12","kind":"other","acquired":true,"shares":36800,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock."}],"balance_after":36800,"derivative":{"exercise_price":6.25,"exercise_date":"2018-11-12","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":36800},"source":{"system":"sec-edgar","filing":"0001213900-18-015548","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018015548/ownership.xml","form_type":"4"}},{"id":3767501,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to purchase common stock","published_at":"2018-11-13T18:05:35.000Z","date":"2018-11-12","kind":"other","acquired":true,"shares":36800,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock."}],"balance_after":36800,"derivative":{"exercise_price":5,"exercise_date":"2018-11-12","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":36800},"source":{"system":"sec-edgar","filing":"0001213900-18-015548","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018015548/ownership.xml","form_type":"4"}},{"id":3767500,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to purchase units","published_at":"2018-11-13T18:05:35.000Z","date":"2018-11-12","kind":"other","acquired":false,"shares":36800,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":5,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Units","underlying_shares":73600},"source":{"system":"sec-edgar","filing":"0001213900-18-015548","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018015548/ownership.xml","form_type":"4"}},{"id":3855122,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T16:14:33.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On July 31, 2018, Mr. Stilley purchased 80,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 31, 2018, Mr. Stilley purchased 80,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."}],"balance_after":169027,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001213900-18-010095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018010095/ownership.xml","form_type":"4"}},{"id":3855121,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to purchase units","published_at":"2018-08-02T16:14:33.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":36800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The warrant to purchase 36,800 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 73,600 shares."}],"balance_after":36800,"derivative":{"exercise_price":5,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Units","underlying_shares":73600},"source":{"system":"sec-edgar","filing":"0001213900-18-010095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018010095/ownership.xml","form_type":"4"}},{"id":3855120,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T16:14:33.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":52227,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering."}],"balance_after":89027,"derivative":{"exercise_price":6.25,"underlying":"Common Stock","underlying_shares":52227},"source":{"system":"sec-edgar","filing":"0001213900-18-010095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018010095/ownership.xml","form_type":"4"}},{"id":3855119,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T16:14:33.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":36800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 36,800 shares of common stock and warrant to purchase 36,800 shares of common stock were received by the reporting person upon consummation of the initial public offering on July 31, 2018 in accordance with a Securities Purchase Agreement dated February 22, 2018."}],"balance_after":36800,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":36800},"source":{"system":"sec-edgar","filing":"0001213900-18-010095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018010095/ownership.xml","form_type":"4"}},{"id":3855118,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Note","published_at":"2018-08-02T16:14:33.000Z","date":"2018-07-31","kind":"exercise","acquired":false,"shares":52227,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering."}],"balance_after":0,"derivative":{"exercise_price":0.44,"underlying":"Common Stock","underlying_shares":52227},"source":{"system":"sec-edgar","filing":"0001213900-18-010095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018010095/ownership.xml","form_type":"4"}},{"id":3855117,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-02T16:14:33.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On July 31, 2018, Mr. Stilley purchased 80,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 31, 2018, Mr. Stilley purchased 80,000 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."}],"balance_after":504000,"source":{"system":"sec-edgar","filing":"0001213900-18-010095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018010095/ownership.xml","form_type":"4"}},{"id":3855116,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-02T16:14:33.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":52227,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering."}],"balance_after":424629,"source":{"system":"sec-edgar","filing":"0001213900-18-010095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018010095/ownership.xml","form_type":"4"}},{"id":3855115,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":113130,"kind":"person","name":"Stilley William B. III","position":1,"cik":"0001718069","reported_name":"Stilley William B. III","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-02T16:14:33.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":36800,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 36,800 shares of common stock and warrant to purchase 36,800 shares of common stock were received by the reporting person upon consummation of the initial public offering on July 31, 2018 in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 36,800 shares of common stock and warrant to purchase 36,800 shares of common stock were received by the reporting person upon consummation of the initial public offering on July 31, 2018 in accordance with a Securities Purchase Agreement dated February 22, 2018."}],"balance_after":372402,"source":{"system":"sec-edgar","filing":"0001213900-18-010095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718069/000121390018010095/ownership.xml","form_type":"4"}}]}